Meningococcal polysaccharide vaccines: A review

Polysaccharides produced by Neisseria meningitidis are pharmaceutically important molecules, and are the active components of vaccines against N. meningitidis serogroups A, C, W135 and Y. Effective vaccines based on capsular polysaccharide, polysaccharide conjugates and outer membrane vesicles have...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Carbohydrate polymers 2009-02, Vol.75 (4), p.553-565
Hauptverfasser: Joshi, Varsha S., Bajaj, Ishwar B., Survase, Shrikant A., Singhal, Rekha S., Kennedy, John F.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 565
container_issue 4
container_start_page 553
container_title Carbohydrate polymers
container_volume 75
creator Joshi, Varsha S.
Bajaj, Ishwar B.
Survase, Shrikant A.
Singhal, Rekha S.
Kennedy, John F.
description Polysaccharides produced by Neisseria meningitidis are pharmaceutically important molecules, and are the active components of vaccines against N. meningitidis serogroups A, C, W135 and Y. Effective vaccines based on capsular polysaccharide, polysaccharide conjugates and outer membrane vesicles have been developed for strains expressing capsular polysaccharides that define the sero groups A, C, Y and W135. However, conventional approaches to develop a vaccine for group B strains have been largely unsuccessful. This review focuses on the various aspects of fermentative production of meningococcal polysaccharide from N. meningitidis, methods of conjugation for improving the immunogenicity of polysaccharide vaccine, and efficient and cost effective methods for the purification of N. meningitidis capsular polysaccharide and outer membrane vesicles. In addition, different analytical techniques for the quantitative determination of polysaccharide vaccine and evaluation of structural integrity of conjugate vaccine have been described.
doi_str_mv 10.1016/j.carbpol.2008.09.032
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_19657206</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0144861708004645</els_id><sourcerecordid>19657206</sourcerecordid><originalsourceid>FETCH-LOGICAL-c436t-5fd2852ce8594587d57a628dc50e126c8574eaf4cb6bc5c17604c99fbb20a6de3</originalsourceid><addsrcrecordid>eNqFkM1OwzAQhC0EEqXwCEi5wC3p2rGdhAuqKv6kIi5wtpzNBlylSbHbor49rlpxZS-7h5lZzcfYNYeMA9eTRYbW16uhywRAmUGVQS5O2IiXRZXyXMpTNgIuZVpqXpyzixAWEEdzGLHJK_Wu_xxwQLRdEkN2wSJ-We8aSrbxdD2Fu2SaeNo6-rlkZ63tAl0d95h9PD68z57T-dvTy2w6T1Hmep2qthGlEkilqqQqi0YVVouyQQXEhcZSFZJsK7HWNSrkhQaJVdXWtQCrG8rH7PaQu_LD94bC2ixdQOo629OwCYZXWhUCdBSqgxD9EIKn1qy8W1q_MxzMHo9ZmCMes8djoDIRT_TdHB_YEJu33vbowp9ZcJFzATzq7g86im0jAW8COuqRGucJ16YZ3D-ffgFrAn0b</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19657206</pqid></control><display><type>article</type><title>Meningococcal polysaccharide vaccines: A review</title><source>Elsevier ScienceDirect Journals</source><creator>Joshi, Varsha S. ; Bajaj, Ishwar B. ; Survase, Shrikant A. ; Singhal, Rekha S. ; Kennedy, John F.</creator><creatorcontrib>Joshi, Varsha S. ; Bajaj, Ishwar B. ; Survase, Shrikant A. ; Singhal, Rekha S. ; Kennedy, John F.</creatorcontrib><description>Polysaccharides produced by Neisseria meningitidis are pharmaceutically important molecules, and are the active components of vaccines against N. meningitidis serogroups A, C, W135 and Y. Effective vaccines based on capsular polysaccharide, polysaccharide conjugates and outer membrane vesicles have been developed for strains expressing capsular polysaccharides that define the sero groups A, C, Y and W135. However, conventional approaches to develop a vaccine for group B strains have been largely unsuccessful. This review focuses on the various aspects of fermentative production of meningococcal polysaccharide from N. meningitidis, methods of conjugation for improving the immunogenicity of polysaccharide vaccine, and efficient and cost effective methods for the purification of N. meningitidis capsular polysaccharide and outer membrane vesicles. In addition, different analytical techniques for the quantitative determination of polysaccharide vaccine and evaluation of structural integrity of conjugate vaccine have been described.</description><identifier>ISSN: 0144-8617</identifier><identifier>EISSN: 1879-1344</identifier><identifier>DOI: 10.1016/j.carbpol.2008.09.032</identifier><identifier>CODEN: CAPOD8</identifier><language>eng</language><publisher>Kidlington: Elsevier Ltd</publisher><subject>Bacterial diseases ; Bacterial diseases of the nervous system. Bacterial myositis ; Bacterial meningitis ; Biological and medical sciences ; General pharmacology ; Human bacterial diseases ; Infectious diseases ; Medical sciences ; Neisseria meningitidis ; Outer membrane vesicle ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Polysaccharide conjugate vaccines ; Polysaccharide vaccines ; Prevention and actions ; Public health. Hygiene ; Public health. Hygiene-occupational medicine ; Specific populations (family, woman, child, elderly...)</subject><ispartof>Carbohydrate polymers, 2009-02, Vol.75 (4), p.553-565</ispartof><rights>2008 Elsevier Ltd</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c436t-5fd2852ce8594587d57a628dc50e126c8574eaf4cb6bc5c17604c99fbb20a6de3</citedby><cites>FETCH-LOGICAL-c436t-5fd2852ce8594587d57a628dc50e126c8574eaf4cb6bc5c17604c99fbb20a6de3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0144861708004645$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21231201$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Joshi, Varsha S.</creatorcontrib><creatorcontrib>Bajaj, Ishwar B.</creatorcontrib><creatorcontrib>Survase, Shrikant A.</creatorcontrib><creatorcontrib>Singhal, Rekha S.</creatorcontrib><creatorcontrib>Kennedy, John F.</creatorcontrib><title>Meningococcal polysaccharide vaccines: A review</title><title>Carbohydrate polymers</title><description>Polysaccharides produced by Neisseria meningitidis are pharmaceutically important molecules, and are the active components of vaccines against N. meningitidis serogroups A, C, W135 and Y. Effective vaccines based on capsular polysaccharide, polysaccharide conjugates and outer membrane vesicles have been developed for strains expressing capsular polysaccharides that define the sero groups A, C, Y and W135. However, conventional approaches to develop a vaccine for group B strains have been largely unsuccessful. This review focuses on the various aspects of fermentative production of meningococcal polysaccharide from N. meningitidis, methods of conjugation for improving the immunogenicity of polysaccharide vaccine, and efficient and cost effective methods for the purification of N. meningitidis capsular polysaccharide and outer membrane vesicles. In addition, different analytical techniques for the quantitative determination of polysaccharide vaccine and evaluation of structural integrity of conjugate vaccine have been described.</description><subject>Bacterial diseases</subject><subject>Bacterial diseases of the nervous system. Bacterial myositis</subject><subject>Bacterial meningitis</subject><subject>Biological and medical sciences</subject><subject>General pharmacology</subject><subject>Human bacterial diseases</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Neisseria meningitidis</subject><subject>Outer membrane vesicle</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Polysaccharide conjugate vaccines</subject><subject>Polysaccharide vaccines</subject><subject>Prevention and actions</subject><subject>Public health. Hygiene</subject><subject>Public health. Hygiene-occupational medicine</subject><subject>Specific populations (family, woman, child, elderly...)</subject><issn>0144-8617</issn><issn>1879-1344</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNqFkM1OwzAQhC0EEqXwCEi5wC3p2rGdhAuqKv6kIi5wtpzNBlylSbHbor49rlpxZS-7h5lZzcfYNYeMA9eTRYbW16uhywRAmUGVQS5O2IiXRZXyXMpTNgIuZVpqXpyzixAWEEdzGLHJK_Wu_xxwQLRdEkN2wSJ-We8aSrbxdD2Fu2SaeNo6-rlkZ63tAl0d95h9PD68z57T-dvTy2w6T1Hmep2qthGlEkilqqQqi0YVVouyQQXEhcZSFZJsK7HWNSrkhQaJVdXWtQCrG8rH7PaQu_LD94bC2ixdQOo629OwCYZXWhUCdBSqgxD9EIKn1qy8W1q_MxzMHo9ZmCMes8djoDIRT_TdHB_YEJu33vbowp9ZcJFzATzq7g86im0jAW8COuqRGucJ16YZ3D-ffgFrAn0b</recordid><startdate>20090201</startdate><enddate>20090201</enddate><creator>Joshi, Varsha S.</creator><creator>Bajaj, Ishwar B.</creator><creator>Survase, Shrikant A.</creator><creator>Singhal, Rekha S.</creator><creator>Kennedy, John F.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope></search><sort><creationdate>20090201</creationdate><title>Meningococcal polysaccharide vaccines: A review</title><author>Joshi, Varsha S. ; Bajaj, Ishwar B. ; Survase, Shrikant A. ; Singhal, Rekha S. ; Kennedy, John F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c436t-5fd2852ce8594587d57a628dc50e126c8574eaf4cb6bc5c17604c99fbb20a6de3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Bacterial diseases</topic><topic>Bacterial diseases of the nervous system. Bacterial myositis</topic><topic>Bacterial meningitis</topic><topic>Biological and medical sciences</topic><topic>General pharmacology</topic><topic>Human bacterial diseases</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Neisseria meningitidis</topic><topic>Outer membrane vesicle</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Polysaccharide conjugate vaccines</topic><topic>Polysaccharide vaccines</topic><topic>Prevention and actions</topic><topic>Public health. Hygiene</topic><topic>Public health. Hygiene-occupational medicine</topic><topic>Specific populations (family, woman, child, elderly...)</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Joshi, Varsha S.</creatorcontrib><creatorcontrib>Bajaj, Ishwar B.</creatorcontrib><creatorcontrib>Survase, Shrikant A.</creatorcontrib><creatorcontrib>Singhal, Rekha S.</creatorcontrib><creatorcontrib>Kennedy, John F.</creatorcontrib><collection>Pascal-Francis</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Carbohydrate polymers</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Joshi, Varsha S.</au><au>Bajaj, Ishwar B.</au><au>Survase, Shrikant A.</au><au>Singhal, Rekha S.</au><au>Kennedy, John F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Meningococcal polysaccharide vaccines: A review</atitle><jtitle>Carbohydrate polymers</jtitle><date>2009-02-01</date><risdate>2009</risdate><volume>75</volume><issue>4</issue><spage>553</spage><epage>565</epage><pages>553-565</pages><issn>0144-8617</issn><eissn>1879-1344</eissn><coden>CAPOD8</coden><abstract>Polysaccharides produced by Neisseria meningitidis are pharmaceutically important molecules, and are the active components of vaccines against N. meningitidis serogroups A, C, W135 and Y. Effective vaccines based on capsular polysaccharide, polysaccharide conjugates and outer membrane vesicles have been developed for strains expressing capsular polysaccharides that define the sero groups A, C, Y and W135. However, conventional approaches to develop a vaccine for group B strains have been largely unsuccessful. This review focuses on the various aspects of fermentative production of meningococcal polysaccharide from N. meningitidis, methods of conjugation for improving the immunogenicity of polysaccharide vaccine, and efficient and cost effective methods for the purification of N. meningitidis capsular polysaccharide and outer membrane vesicles. In addition, different analytical techniques for the quantitative determination of polysaccharide vaccine and evaluation of structural integrity of conjugate vaccine have been described.</abstract><cop>Kidlington</cop><pub>Elsevier Ltd</pub><doi>10.1016/j.carbpol.2008.09.032</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0144-8617
ispartof Carbohydrate polymers, 2009-02, Vol.75 (4), p.553-565
issn 0144-8617
1879-1344
language eng
recordid cdi_proquest_miscellaneous_19657206
source Elsevier ScienceDirect Journals
subjects Bacterial diseases
Bacterial diseases of the nervous system. Bacterial myositis
Bacterial meningitis
Biological and medical sciences
General pharmacology
Human bacterial diseases
Infectious diseases
Medical sciences
Neisseria meningitidis
Outer membrane vesicle
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Polysaccharide conjugate vaccines
Polysaccharide vaccines
Prevention and actions
Public health. Hygiene
Public health. Hygiene-occupational medicine
Specific populations (family, woman, child, elderly...)
title Meningococcal polysaccharide vaccines: A review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T06%3A30%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Meningococcal%20polysaccharide%20vaccines:%20A%20review&rft.jtitle=Carbohydrate%20polymers&rft.au=Joshi,%20Varsha%20S.&rft.date=2009-02-01&rft.volume=75&rft.issue=4&rft.spage=553&rft.epage=565&rft.pages=553-565&rft.issn=0144-8617&rft.eissn=1879-1344&rft.coden=CAPOD8&rft_id=info:doi/10.1016/j.carbpol.2008.09.032&rft_dat=%3Cproquest_cross%3E19657206%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=19657206&rft_id=info:pmid/&rft_els_id=S0144861708004645&rfr_iscdi=true